Early Detection Research Network

Biomarkers: the key to early detection

Navigation

Personal tools

You are here: Home / Protocols / Biomarker Dev Lab At Moffitt Supplement

Abbreviated Name: Biomarker Dev Lab At Moffitt Supplement

Protocol ID: 72

Lead Investigator: Tockman, Melvyn S. — H. Lee Moffitt Cancer Center

Coordinating Investigator:

No coordinating investigator defined.

Involved Investigator Sites:

Biomarker Name:

Design:

Field(s) of Research: UNKNOWN

Collaborative Group Text: Lung and Upper Aerodigestive Cancers Research Group

Phased Status:

Abstract:

Aims:

Analytic Method:

Comments:

Biomarkers:

There are currently no biomarkers annotated for this protocol.

Datasets:

No datasets are currently associated with this protocol.

: Announcement 03/14/2018
Thank you to everyone to made the 10th EDRN Scientific Workshop a success. The next event is the 33rd EDRN Steering Committee Meeting from September 5-6, 2018 in Boston, MA. Details will be available soon.

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.; Announcement 10/23/2017

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

EDRN Founder Honored: Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.